Literature DB >> 22869734

Oncogenic Myc translocations are independent of chromosomal location and orientation of the immunoglobulin heavy chain locus.

Elizabeth Spehalski1, Alexander L Kovalchuk, John T Collins, Genqing Liang, Wendy Dubois, Herbert C Morse, David O Ferguson, Rafael Casellas, Wesley A Dunnick.   

Abstract

Many tumors are characterized by recurrent translocations between a tissue-specific gene and a proto-oncogene. The juxtaposition of the Ig heavy chain gene and Myc in Burkitt's lymphoma and in murine plasmacytoma is a classic example. Regulatory elements within the heavy chain constant region locus are required for Myc translocation and/or deregulation. However, many genes are regulated by cis-acting elements at distances up to 1,000 kb outside the locus. Such putative distal elements have not been examined for the heavy chain locus, particularly in the context of Myc translocations. We demonstrate that a transgene containing the Ig heavy chain constant region locus, inserted into five different chromosomal locations, can undergo translocations involving Myc. Furthermore, these translocations are able to generate plasmacytomas in each transgenic line. We conclude that the heavy chain constant region locus itself includes all of the elements necessary for both the translocation and the deregulation of the proto-oncogene.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22869734      PMCID: PMC3427096          DOI: 10.1073/pnas.1202882109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  Mechanisms of chromosomal translocations in B cell lymphomas.

Authors:  R Küppers; R Dalla-Favera
Journal:  Oncogene       Date:  2001-09-10       Impact factor: 9.867

2.  Spatial proximity of translocation-prone gene loci in human lymphomas.

Authors:  Jeffrey J Roix; Philip G McQueen; Peter J Munson; Luis A Parada; Tom Misteli
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

3.  Conservation of relative chromosome positioning in normal and cancer cells.

Authors:  Luis A Parada; Philip G McQueen; Peter J Munson; Tom Misteli
Journal:  Curr Biol       Date:  2002-10-01       Impact factor: 10.834

Review 4.  Mechanism and control of class-switch recombination.

Authors:  John P Manis; Ming Tian; Frederick W Alt
Journal:  Trends Immunol       Date:  2002-01       Impact factor: 16.687

5.  Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme.

Authors:  M Muramatsu; K Kinoshita; S Fagarasan; S Yamada; Y Shinkai; T Honjo
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

6.  Germline transcription and switch recombination of a transgene containing the entire H chain constant region locus: effect of a mutation in a STAT6 binding site in the gamma 1 promoter.

Authors:  Wesley A Dunnick; Jian Shi; Kevin A Graves; John T Collins
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

Review 7.  Neoplastic development in plasma cells.

Authors:  Michael Potter
Journal:  Immunol Rev       Date:  2003-08       Impact factor: 12.988

8.  AID is required for c-myc/IgH chromosome translocations in vivo.

Authors:  Almudena R Ramiro; Mila Jankovic; Thomas Eisenreich; Simone Difilippantonio; Selina Chen-Kiang; Masamichi Muramatsu; Tasuku Honjo; André Nussenzweig; Michel C Nussenzweig
Journal:  Cell       Date:  2004-08-20       Impact factor: 41.582

9.  Variant (6 ; 15) translocation in a murine plasmacytoma occurs near an immunoglobulin kappa gene but far from the myc oncogene.

Authors:  E Webb; J M Adams; S Cory
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

10.  Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells.

Authors:  Sean Rooney; JoAnn Sekiguchi; Scott Whitlow; Mark Eckersdorff; John P Manis; Charles Lee; David O Ferguson; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

View more
  4 in total

1.  Acceleration of tumor growth due to dysfunction in M1 macrophages and enhanced angiogenesis in an animal model of autoimmune disease.

Authors:  Tomoyuki Kondo; Takaaki Tsunematsu; Akiko Yamada; Rieko Arakaki; Masako Saito; Kunihiro Otsuka; Satoko Kujiraoka; Aya Ushio; Mie Kurosawa; Yasusei Kudo; Naozumi Ishimaru
Journal:  Lab Invest       Date:  2016-01-25       Impact factor: 5.662

Review 2.  The IgH 3' regulatory region and c-myc-induced B-cell lymphomagenesis.

Authors:  Nour Ghazzaui; Alexis Saintamand; Hussein Issaoui; Christelle Vincent-Fabert; Yves Denizot
Journal:  Oncotarget       Date:  2017-01-24

3.  Atypical rearrangement involving 3'-IGH@ and a breakpoint at least 400 Kb upstream of an intact MYC in a CLL patient with an apparently balanced t(8;14)(q24.1;q32) and negative MYC expression.

Authors:  Ina Amarillo; Peter H Bui; Sibel Kantarci; Nagesh Rao; Brit S Shackley; Rolando García; Carlos A Tirado
Journal:  Mol Cytogenet       Date:  2013-02-01       Impact factor: 2.009

4.  3'Igh enhancers hs3b/hs4 are dispensable for Myc deregulation in mouse plasmacytomas with T(12;15) translocations.

Authors:  Alexander L Kovalchuk; Tomomi Sakai; Chen-Feng Qi; Wendy Du Bois; Wesley A Dunnick; Michel Cogné; Herbert C Morse
Journal:  Oncotarget       Date:  2018-10-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.